SB 495 Maryland Senate · 2026 Regular Session

Health - Newborn Screening Program - Gaucher Disease

SB 495 requires Maryland's Department of Health to add Gaucher disease screening to the state's mandatory newborn screening program. This affects all newborns in Maryland, as the bill mandates screening for Gaucher disease alongside other hereditary disorders under existing law. The key mechanism is amending Section 13-111 of Maryland's health code to explicitly include Gaucher disease in the list of conditions screened for, effective October 1, 2026. The bill does not alter funding or reporting procedures but directly expands the scope of the current newborn screening system to cover this specific genetic condition.
Bill status in committee 1 of 4 stages cleared
Introduction
Feb 2026
Committee Review
Floor Vote
Governor
Introduced Feb 2, 2026 Last action Feb 4, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Feb 2, 2026
Committee
First Reading Finance
upper
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of Shelly Hettleman
Shelly Hettleman
DDemocratic
MD
11